一众新药的密集推进，让ACH治疗的市场竞争日渐激烈。对于一个患者基数有限但需终身或长期干预的罕见病市场来说，每1厘米的年生长疗效差异，从注射到口服的跨越、从日用到周剂的改进，都将成为决定未来市场格局的关键因素。
Explore our full range of subscriptions.For individuals
。服务器推荐对此有专业解读
FT App on Android & iOS，这一点在爱思助手下载最新版本中也有详细论述
But the Cabinet Office said it was committed to the inquiry and learning the lessons for the future.